Trospium chloride
(Redirected from Trospium)
A medication used to treat overactive bladder
Trospium chloride is a medication used to treat overactive bladder symptoms such as urinary incontinence, urinary urgency, and urinary frequency. It is classified as an antimuscarinic agent, which works by relaxing the detrusor muscle in the bladder, thereby reducing the symptoms associated with overactive bladder.
Pharmacology[edit | edit source]
Trospium chloride is a quaternary ammonium compound that acts as a muscarinic receptor antagonist. It has a high affinity for the M1, M2, and M3 muscarinic receptors, with a particular emphasis on the M3 receptor, which is primarily responsible for bladder contraction. By inhibiting these receptors, trospium chloride reduces involuntary bladder contractions and increases bladder capacity.
Mechanism of Action[edit | edit source]
The primary mechanism of action of trospium chloride involves the competitive inhibition of the muscarinic receptors in the bladder. This inhibition prevents the binding of acetylcholine, a neurotransmitter that stimulates bladder contractions. As a result, the detrusor muscle remains relaxed, reducing the frequency and urgency of urination.
Pharmacokinetics[edit | edit source]
Trospium chloride is poorly absorbed from the gastrointestinal tract, with an oral bioavailability of approximately 10%. It is metabolized in the liver and excreted primarily in the urine. The drug has a half-life of approximately 20 hours, allowing for once or twice daily dosing.
Clinical Use[edit | edit source]
Trospium chloride is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. It is available in both immediate-release and extended-release formulations. The extended-release form allows for once-daily dosing, which can improve patient compliance.
Side Effects[edit | edit source]
Common side effects of trospium chloride include dry mouth, constipation, headache, and dizziness. Due to its anticholinergic properties, it may also cause blurred vision and urinary retention. Patients with narrow-angle glaucoma, myasthenia gravis, or severe gastrointestinal obstruction should use this medication with caution.
Contraindications[edit | edit source]
Trospium chloride is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. It should be used with caution in patients with hepatic impairment or renal impairment, as these conditions may affect the drug's metabolism and excretion.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD